Multiple endocrine neoplasia type 1 interacts with forkhead transcription factor CHES1 in DNA damage response
about
Menin stimulates homology-directed DNA repairInherited pancreatic endocrine tumor syndromes: advances in molecular pathogenesis, diagnosis, management, and controversiesThe same pocket in menin binds both MLL and JUND but has opposite effects on transcriptionMEN1, MEN4, and Carney Complex: Pathology and Molecular GeneticsMenin links the stress response to genome stability in Drosophila melanogasterClinical and molecular genetics of parathyroid neoplasmsCranial muscles in amphibians: development, novelties and the role of cranial neural crest cells.Reversal of preexisting hyperglycemia in diabetic mice by acute deletion of the Men1 gene.MicroRNA-574-5p was pivotal for TLR9 signaling enhanced tumor progression via down-regulating checkpoint suppressor 1 in human lung cancerVariable clinical expression in patients with a germline MEN1 disease gene mutation: clues to a genotype-phenotype correlation.MEN1 and FANCD2 mediate distinct mechanisms of DNA crosslink repair.Multiple endocrine neoplasia type 1 (MEN1) as a cancer predisposition syndrome: clues into the mechanisms of MEN1-related carcinogenesis.Loss of MEN1 activates DNMT1 implicating DNA hypermethylation as a driver of MEN1 tumorigenesis.FOXN3 Regulates Hepatic Glucose Utilization.Distinct pathways regulated by menin and by MLL1 in hematopoietic stem cells and developing B cells.The transcription factor FOXN3 inhibits cell proliferation by downregulating E2F5 expression in hepatocellular carcinoma cells.CHES1/FOXN3 regulates cell proliferation by repressing PIM2 and protein biosynthesis.Menin and bone metabolism.Genetics of multiple endocrine neoplasia type 1 syndrome: what's new and what's old.Loss of RASSF1A synergizes with deregulated RUNX2 signaling in tumorigenesis.Deletion of the Men1 gene prevents streptozotocin-induced hyperglycemia in mice.Characterization of DNA damage-dependent cell cycle checkpoints in a menin-deficient model.Imaging in multiple endocrine neoplasia type 1: recent studies show enhanced sensitivities but increased controversies.The future: genetics advances in MEN1 therapeutic approaches and management strategies.The FOXN3-NEAT1-SIN3A repressor complex promotes progression of hormonally responsive breast cancer.Treatment of Pancreatic Neuroendocrine Tumors in Multiple Endocrine Neoplasia Type 1: Some Clarity But Continued Controversy.Checkpoint suppressor 1 suppresses transcriptional activity of ERα and breast cancer cell proliferation via deacetylase SIRT1.
P2860
Q24304240-81B8C7A2-2C96-4A8F-A054-AE0C64720AE6Q24647838-165B0EEB-3C36-40DF-8FEB-BA0DD3138D59Q27677227-18E76D77-1432-4206-BFF5-405A1519551BQ28088746-AA7F04FE-950B-4E56-AA53-77EC15C86FB0Q33761355-62092F7C-E552-4354-8E92-35B9B9F4A394Q34125668-816D7B1F-7149-4AE2-B21E-923D3A43BDB0Q34332285-95D11E49-E723-456A-B40A-DA7A5D67BD05Q34377543-D754A88F-A6CB-47E0-962F-391000D88B4AQ34469678-0A88B3D2-7AC3-42C7-80B8-BCE4F382A5FAQ35895504-FF1EE4F6-8433-4C2A-B3F8-331D998632E3Q36514229-B37E58C8-006D-4BDC-968F-09FE411671F9Q36973287-6901288E-C586-4EC0-B6CC-40D93E79EF44Q37022247-06EBCC06-3543-48E4-93BD-CEBE7261BD11Q37029790-9310C8EA-4115-4564-9B6B-AE91FD37DD66Q37186452-717C7994-24E2-4D1B-B06A-765A884EB8C0Q37536628-62F39701-F9F9-4669-AB9B-842487DAC173Q37607524-D990A9F7-AD2F-478F-AF7F-A38959B336C7Q38006379-480E4255-AA54-44F9-9CF7-B6B11E31C9EBQ39129029-FCB597FC-A9AB-4E1E-875B-74EC2214216FQ41018220-739BFF1A-D2E8-4736-8D84-592AD5B20631Q42086741-D103A527-C99A-401E-A38B-66E0DBC9EE16Q42142535-7F3C2A93-2945-493B-9BE2-EDE493B211BEQ43066318-BA18E073-84EE-474D-8034-476B13032063Q47814736-3CD9EB12-FC00-430D-B293-21B5E3FDE76FQ47956744-7A382B14-9A71-4426-8725-9C2CB70B1443Q54638848-A2DDFB4A-3BED-4583-A881-EEBBE5F69204Q55367849-01A05322-0DF5-404C-88D6-65A68AA6C672
P2860
Multiple endocrine neoplasia type 1 interacts with forkhead transcription factor CHES1 in DNA damage response
description
2006 nî lūn-bûn
@nan
2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Multiple endocrine neoplasia t ...... r CHES1 in DNA damage response
@ast
Multiple endocrine neoplasia t ...... r CHES1 in DNA damage response
@en
Multiple endocrine neoplasia t ...... r CHES1 in DNA damage response
@en-gb
Multiple endocrine neoplasia t ...... r CHES1 in DNA damage response
@nl
type
label
Multiple endocrine neoplasia t ...... r CHES1 in DNA damage response
@ast
Multiple endocrine neoplasia t ...... r CHES1 in DNA damage response
@en
Multiple endocrine neoplasia t ...... r CHES1 in DNA damage response
@en-gb
Multiple endocrine neoplasia t ...... r CHES1 in DNA damage response
@nl
prefLabel
Multiple endocrine neoplasia t ...... r CHES1 in DNA damage response
@ast
Multiple endocrine neoplasia t ...... r CHES1 in DNA damage response
@en
Multiple endocrine neoplasia t ...... r CHES1 in DNA damage response
@en-gb
Multiple endocrine neoplasia t ...... r CHES1 in DNA damage response
@nl
P2093
P921
P3181
P1433
P1476
Multiple endocrine neoplasia t ...... r CHES1 in DNA damage response
@en
P2093
Allen E Bale
Kenneth L Scott
Molly C Kottemann
Sharon E Plon
Valeria Busygina
P304
P3181
P356
10.1158/0008-5472.CAN-06-0061
P407
P577
2006-09-01T00:00:00Z